• MS Multiple sclerosis, neuromyletis optica research clinical trials

The UC Davis Neurology Department’s faculty members and research staff conduct both basic and clinical research aimed at developing new treatments for Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO).

Clinical research

The participation of our study volunteers in controlled clinical trials has enabled our researchers to help develop new drugs that show promise as future treatments for MS. Patients who would like to assist our ongoing research efforts may be able to participate in clinical trials designed to test these as well as other new therapies for MS and NMO.

Open Studies Currently Enrolling Participants at UC Davis

MULTIPLE SCLEROSIS

Abbvie M14-397 Study: A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Progressive Forms of Multiple Sclersosis:
For more information, enter NCT03737812 into the search box at www.clinicaltrials.gov (http://www.clinicaltrials.gov)

Abbvie M18-918 Study: A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Safety and Efficacy of Elezanumab when Added to Standard of Care in Relapsing Forms of Multiple Sclersosis:
For more information, enter NCT 03737851 into the search box at www.clinicaltrials.gov (http://www.clinicaltrials.gov)

If you are interested in participating or want more information on our clinical trials, please contact:

Janelle Butters, NP, at (916) 734-6276, jbutters@ucdavis.edu